RxDoctor Payments Data

Maria Reed, PA

Physician Assistant · East Lansing, MINPI 1629082482

Payments from drug & device makers

$4,003in general payments, 2019–2025

Across 176 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$478
  • Takeda Pharmaceuticals U.S.A., Inc.$387
  • Sanofi$302
  • Pfizer$195
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$192
  • plus $956 from 14 others

What the payments were for

  • Food & beverage$3,89097%
  • Education$1143%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,003 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$16,146
Medicare patients
128
Services billed
176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase23$36,739
LinzessLinaclotide36$28,794
TrulancePlecanatide27$14,315
Mesalamine17$10,196
Pantoprazole Sodium258$3,253
Lubiprostone17$2,926
Lansoprazole13$2,795
Omeprazole163$2,314
Dicyclomine Hcl17$636
Esomeprazole Magnesium22$490
Famotidine67$408
Lactulose13$402
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine12$278
Azathioprine12$194
Prochlorperazine Maleate12$194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,494$65,53259 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$192$14,31527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in East Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →